HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complement receptors (C3b, C4b/C3d) unbalance on CLL lymphocytes.

Abstract
A study of lymphocytes bearing C3b, C4b and C3d complement receptor (CRL) was performed on human peripheral blood from 16 healthy donors and 12 patients affected with Chronic Lymphatic Leukemia (CLL). In the latter group a clear rise of C3dCRL was demonstrated, when compared with immunoadherence receptors bearing lymphocytes. However, when compared with controls, also these latter were slightly augmented. Furthermore in CLL under treatment CRL populations showed the same profile as CLL: so it was suggested that the treatment reduced not selectively all the three types of CRL, within the population of sIg bearing lymphocytes. Here we discuss the hypothesis that, in CLL, the proliferating lymphocytes population is chiefly sIg+, C3d+/C3b-, C4b-, but also sIg+, C3d+/C3b+, C4b+.
AuthorsB Perussia, P Casali, G Joppolo, P Borzini
JournalBollettino dell'Istituto sieroterapico milanese (Boll Ist Sieroter Milan) Vol. 55 Issue 3 Pg. 235-40 (Jul 31 1976) ISSN: 0021-2547 [Print] Italy
PMID1087884 (Publication Type: Journal Article)
Chemical References
  • Antigens, Neoplasm
  • Complement C3
  • Complement C4
  • Complement System Proteins
Topics
  • Animals
  • Antibody Formation
  • Antigens, Neoplasm (analysis)
  • B-Lymphocytes (immunology)
  • Cell Membrane (immunology)
  • Complement C3 (isolation & purification)
  • Complement C4 (isolation & purification)
  • Complement System Proteins (isolation & purification)
  • Humans
  • Immune Adherence Reaction
  • Leukemia, Lymphoid (immunology)
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: